A Novel Fluorescent Ductal Needle for Localization and Sampling of Micro Lesions in Breast Ducts
NCT: NCT07339306 · RECRUITING
Brief Summary
This prospective, multicenter cohort study investigates the differences in the reliability of rapid pathology compared to postoperative pathology when utilizing a novel fluorescent localization needle equipped with a controllable shedding quantum dot chiral nanofluorescent coating, in contrast to traditional localization techniques for breast duct lesions. The principal objective is to assess the clinical efficacy of this innovative fluorescent localization needle in enabling precise pathological diagnosis of micro lesions in breast ducts.
Frequently Asked Questions
What is A Novel Fluorescent Ductal Needle for Localization and Sampling of Micro Lesions in Breast Ducts?
A Novel Fluorescent Ductal Needle for Localization and Sampling of Micro Lesions in Breast Ducts is a clinical trial registered under NCT07339306. Current status: RECRUITING.
What is the status of NCT07339306?
The current status of NCT07339306 (A Novel Fluorescent Ductal Needle for Localization and Sampling of Micro Lesions in Breast Ducts) is: RECRUITING.
When did A Novel Fluorescent Ductal Needle for Localization and Sampling of Micro Lesions in Breast Ducts start?
A Novel Fluorescent Ductal Needle for Localization and Sampling of Micro Lesions in Breast Ducts started on 2026-01-01.
Official Source
View on ClinicalTrials.gov →Data sourced from ClinicalTrials.gov API. For the most current status, refer to the official record.